We are live on ! Find out more
BBP icon

Virtus Biotech ETF

27 hedge funds and large institutions have $27M invested in Virtus Biotech ETF in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

569% more capital inflows, than outflows

Capital inflows: $10.3M | Capital outflows: $1.53M

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

29% more funds holding

Funds holding: 21 → 27 (+6)

14.3% more ownership

Funds ownership: 39.97% → 54.27% (+14%)

Holders
27
Holders Change
+6
Holders Change %
+28.57%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BBP Hedge Fund Activity: Q1 2026 in Review

27 of the 8,239 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2026, worth a combined $27M — up 54% from $17.6M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BBP positions and 2 closed out — a net gain of 7 holders — while 8 added to existing stakes and 5 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $2.29M. The largest seller was Prime Capital Investment Advisors, cutting an estimated $566K.

  • 27 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2026, up from 21 in Q4 2025.
  • Funds reported $27M of Virtus Biotech ETF stock for Q1 2026, up 54% quarter-over-quarter.
  • 9 funds opened new Virtus Biotech ETF positions in Q1 2026 and 2 closed out, a net change of +7 holders.
  • The largest Virtus Biotech ETF buyer in Q1 2026 was Susquehanna International Group, an estimated $2.29M added.
  • The largest Virtus Biotech ETF seller in Q1 2026 was Prime Capital Investment Advisors, an estimated $566K sold.

Based on aggregated 13F filings for Q1 2026.